Quality of life in patients with nonvalvular atrial fibrillation treated with oral anticoagulants.

Objectives: Health-related quality of life (HRQL) is a key factor in making anticoagulant treatment decisions. The objective of this study was to assess the HRQL of patients with nonvalvular atrial fibrillation by treatment type: direct oral anticoagulants (DOACs) or vitamin K antagonists (VKAs).

Methods: We carried out a cross-sectional observational study with clinical practice data, gathering demographic and clinical variables.